Your browser doesn't support javascript.
loading
A Unified Strategy to Fluorinated Nucleoside Analogues Via an Electrophilic Manifold.
Neel, Andrew J; Turnbull, Ben W H; Carson, William P; Benkovics, Tamas; Chung, Cheol K; Johnson, Heather C; Liu, Zhuqing; Peng, Feng; Rummelt, Stephan M; Song, Zhiguo Jake; Tan, Lushi; Wang, Lu; Xu, Feng.
Afiliação
  • Neel AJ; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Turnbull BWH; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Carson WP; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Benkovics T; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Chung CK; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Johnson HC; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Liu Z; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Peng F; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Rummelt SM; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Song ZJ; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Tan L; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Wang L; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Xu F; Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
Org Lett ; 24(41): 7701-7706, 2022 10 21.
Article em En | MEDLINE | ID: mdl-36227065
ABSTRACT
Herein, we present a strategy for the preparation of 3'-fluorinated nucleoside analogues via the aminocatalytic, electrophilic fluorination of readily accessible and bench-stable 2'-ketonucleosides. Initially developed to facilitate the manufacture of 3'-fluoroguanosine (3'-FG)─a substructure of anticancer therapeutic MK-1454─this strategy has been extended to the synthesis of a variety of 3'-fluoronucleosides. Finally, we demonstrate the utility of the 2'-ketonucleoside synthon as a platform for further diversification and suggest that this methodology should be broadly applicable to the discovery of novel nucleoside analogues.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Org Lett Assunto da revista: BIOQUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Org Lett Assunto da revista: BIOQUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos